Intraluminal brachytherapy boost following external beam radiotherapy with concurrent chemotherapy of oesophagus carcinoma: Results of a prospective observational study-Reference-Cited by-同舟云学术

Intraluminal brachytherapy boost following external beam radiotherapy with concurrent chemotherapy of oesophagus carcinoma: Results of a prospective observational study

Published:2018-04 Issue:2 Volume:22 Page:163-166
ISSN:1278-3218
Container-title:Cancer/Radiothérapie
language:en
Short-container-title:Cancer/Radiothérapie

Author:

Nag P.,Gurjar O.P.^ORCID,Bhandari V.,Gupta K.L.,Bagdare P.,Goyal H.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference14 articles.

1. Patterns of cancer incidence, mortality and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world;Kamangar;J Clin Oncol,2006

2. Radiation dose escalation in combined-modality therapy for esophageal cancer;Willett;J Clin Oncol,2002

3. Ten year follow up of esophageal cancer treated by radical radiation: analysis of 869 patients;Sun;Int J Radiat Oncol Biol Phys,1989

4. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma;Urba;J Clin Oncol,2001

5. The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy;Vuong;Int J Radiat Oncol Biol Phys,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brachytherapie;Springer Reference Medizin;2022-11-15

2. A prospective study of radical external beam radiotherapy versus external beam radiotherapy combined with intraluminal brachytherapy for primary esophageal cancer;Brachytherapy;2022-09

3. STUDY TO KNOW THE MORTALITY AND MORBIDITY OF CARCINOMA OESOPHAGUS;INDO AM J PHARM SCI;2018